Liposomal Doxorubicin Market Report 2024-2032: Innovative Liposomal Formulations Pave the Way for Safer and More Effective Cancer Treatments
Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...
Too Old to Operate1d
Optimal Chemotherapy Regimens for Improved Survival in PDAC
The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...
openaccessgovernment7d
A novel approach to cancer chemotherapy
Richard F. Ludueña, Professor Emeritus at the University of Texas Health San Antonio, discusses his innovative approach to ...
Cancer Therapy Advisor1d
PLD Appears Safe, Effective After Platinum Chemo in Patients With Ovarian Cancer
Pegylated liposomal doxorubicin (PLD ... within 12 months or progressed to uncontrolled or refractory disease after ...
News Medical8d
Continuous processing and enhanced control of lipid-based nanoparticles: LNPs and liposomes
Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...
Pharmabiz29d
Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent
Our liposomal drug delivery system offers a safer and more effective ... Haemorrhagic cystitis is a serious condition often resulting from radiation therapy or chemotherapy, marked by severe bleeding ...
EurekAlert!1d
Sylvester Cancer researchers share findings in oral presentations at the ASH 2024 Annual Meeting & Exposition
Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory ...